Company Transgenomic Inc OTC Bulletin Board
Equities
TBIO
US89365K2069
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
|
May. 14 | Precipio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | Precipio, Inc. announced that it expects to receive $0.5 million in funding | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Diagnostic Service
80.1
%
| 8 | 89.4 % | 12 | 80.1 % | +44.67% |
Other
19.9
%
| 1 | 14.9 % | 3 | 19.9 % | +115.34% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 9 | 100.0 % | 15 | 100.0 % | +61.46% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ilan Danieli
CEO | Chief Executive Officer | 52 | 17-06-27 |
Matthew Gage
DFI | Director of Finance/CFO | 57 | 17-06-30 |
Ayman Mohamed
CTO | Chief Tech/Sci/R&D Officer | 40 | - |
Ahmed Zaki Sabet
COO | Chief Operating Officer | 39 | 18-08-06 |
Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Andrews
BRD | Director/Board Member | 64 | 21-02-28 |
Kathy LaPorte
BRD | Director/Board Member | 62 | 18-08-08 |
Richard Sandberg
CHM | Chairman | 81 | 19-12-02 |
Director/Board Member | 68 | Dec. 31 | |
Ilan Danieli
CEO | Chief Executive Officer | 52 | 17-06-27 |
Jeffrey Cossman
BRD | Director/Board Member | 76 | 17-09-25 |
David Cohen
BRD | Director/Board Member | 65 | 17-11-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,469,540 | 1,379,668 ( 93.88 %) | 0 | 93.88 % |
Stock B | 0 | 47 | 0 | 0 |
Company contact information
![address Transgenomic Inc(TBIO)](https://cdn.zonebourse.com/static/address/71213.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-57.58% | 2.09B | |
+19.25% | 1.88B | |
-18.17% | 1.36B | |
+25.65% | 1.28B | |
+2.06% | 798M | |
-33.66% | 762M | |
-36.55% | 724M | |
-30.00% | 586M | |
+16.04% | 560M |
- Stock Market
- Equities
- PRPO Stock
- TBIO Stock
- Company Transgenomic Inc